Zoetis Inc. IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
  FREE IPO Newsletter
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  2011 Secondaries
  2010 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map

For IPO Boutique's "scale of 1 to 5" BUY rating on Zoetis Inc., and our comprehensive analysis, click the "Buy Market Research" link.
Price Range
Issue Price
Trade Date
Zoetis Inc.ZTS
[ NYSE ]
Priced at $26.00 $26.00 $31.5086.1 million2/1/2013
J.P. Morgan, BofA Merrill Lynch, Morgan Stanley
Barclays, Citigroup, Credit Suisse, Deutsche Bank Securities, Goldman Sachs, Guggenheim Securities, Jefferies, BNP Paribas, HSBC, Loop Capital Markets, RBC Capital Markets, Williams Capital Group, UBS Investment Bank, Lebenthal, Piper Jaffray

Filed 2012-08-10

Zoetis Inc. Historical Chart - Click chart for current quote

About Zoetis Inc. (adapted from Zoetis Inc. prospectus):
Zoetis Inc. discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. Measured by their revenues of $4.2 billion for the year ended December 31, 2011, Zoetis is the largest animal health medicines and vaccines business, with products sold in more than 120 countries and across eight core species and five major product categories.

Zoetis directly markets their portfolio of more than 300 product lines to livestock producers and veterinarians located in approximately 70 countries across North America, Europe, Africa, Asia, Australia and Latin America. In markets where they do not have a direct commercial presence, they generally contract with distributors that provide logistics and sales and marketing support for their products.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as "ZTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription

© 2005 - 2017 IPO Boutique. All Rights Reserved